86 related articles for article (PubMed ID: 28508578)
1. Proteomic characterization of EL4 lymphoma-derived tumors upon chemotherapy treatment reveals potential roles for lysosomes and caspase-6 during tumor cell death in vivo.
Kramer DA; Eldeeb MA; Wuest M; Mercer J; Fahlman RP
Proteomics; 2017 Jun; 17(12):. PubMed ID: 28508578
[TBL] [Abstract][Full Text] [Related]
2. In vivo targeting of dead tumor cells in a murine tumor model using a monoclonal antibody specific for the La autoantigen.
Al-Ejeh F; Darby JM; Pensa K; Diener KR; Hayball JD; Brown MP
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5519s-5527s. PubMed ID: 17875784
[TBL] [Abstract][Full Text] [Related]
3. APOMAB, a La-specific monoclonal antibody, detects the apoptotic tumor response to life-prolonging and DNA-damaging chemotherapy.
Al-Ejeh F; Darby JM; Tsopelas C; Smyth D; Manavis J; Brown MP
PLoS One; 2009; 4(2):e4558. PubMed ID: 19247492
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between sensitivity of tumor cells to chemotherapeutic agent in vivo and in vitro: experiment with mouse lymphoma cells].
Li CG; Li ML; Shu XH; Jia YJ; Liu YJ; Li M
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1576-8. PubMed ID: 17785116
[TBL] [Abstract][Full Text] [Related]
5. Effect of Paclitaxel on Antitumor Activity of Cyclophosphamide: Study on Two Transplanted Tumors in Mice.
Kaledin VI; Nikolin VP; Popova NA; Pyshnaya IA; Bogdanova LA; Morozkova TS
Bull Exp Biol Med; 2015 Nov; 160(1):81-3. PubMed ID: 26597686
[TBL] [Abstract][Full Text] [Related]
6. [Effect of lysozyme on the growth of murine lymphoma and antineoplastic activity of cyclophosphamide].
Shcherbakova EG; Bukhman VM; Isakova EB; Bodiagin DA; Arkhipova NA; Rastunova GA; Vorob'eva LS; Lipatov NN
Antibiot Khimioter; 2002; 47(11):3-8. PubMed ID: 12698573
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Bax, Bcl-2 and caspase 3 in hydroxyurea- or etoposide-induced apoptosis of mouse interleukin-3-dependent lymphoma cells.
Olmos G; Prieto A; Herráez A; Tejedor MC; Alvarez-Mon M; Diez JC
Anticancer Res; 2005; 25(2A):999-1007. PubMed ID: 15868939
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 expression correlates with apoptosis induction but not tumor growth delay in transplantable murine lymphomas treated with different chemotherapy drugs.
Story MD; Mirkovic N; Hunter N; Meyn RE
Cancer Chemother Pharmacol; 1999; 44(5):367-71. PubMed ID: 10501909
[TBL] [Abstract][Full Text] [Related]
9. zVAD-fmk upregulates caspase-9 cleavage and activity in etoposide-induced cell death of mouse embryonic fibroblasts.
Rodríguez-Enfedaque A; Delmas E; Guillaume A; Gaumer S; Mignotte B; Vayssière JL; Renaud F
Biochim Biophys Acta; 2012 Aug; 1823(8):1343-52. PubMed ID: 22613767
[TBL] [Abstract][Full Text] [Related]
10. High expression of endogenous bcl-2 and bcl-xL in thymic lymphomas do not diminish their sensitivity to etoposide-induced apoptosis.
Matuszyk J; Kalas W; Cebrat M; Strzadala L
Anticancer Res; 2001; 21(4A):2677-80. PubMed ID: 11724338
[TBL] [Abstract][Full Text] [Related]
11. [Study of the immunological mechanism of anti-tumor effects of 5-FU by establishing EL4 tumor-bearing mouse models].
Li ML; Li CG; Shu XH; Li MX; Jia YJ; Qin ZH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1010-3. PubMed ID: 17988579
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of enriched lysosomes at early phase of camptothecin-induced apoptosis in human U-937 cells.
Parent N; Winstall E; Beauchemin M; Paquet C; Poirier GG; Bertrand R
J Proteomics; 2009 Aug; 72(6):960-73. PubMed ID: 19393779
[TBL] [Abstract][Full Text] [Related]
13. Postchemotherapy and tumor-selective targeting with the La-specific DAB4 monoclonal antibody relates to apoptotic cell clearance.
Al-Ejeh F; Staudacher AH; Smyth DR; Darby JM; Denoyer D; Tsopelas C; Hicks RJ; Brown MP
J Nucl Med; 2014 May; 55(5):772-9. PubMed ID: 24676755
[TBL] [Abstract][Full Text] [Related]
14. [Establishment of EL4 tumor-bearing mouse models and investigation on immunological mechanisms of anti-tumor effect of melphalan].
Li ML; Li CG; Shu XH; Jia YJ; Qin ZH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):235-8. PubMed ID: 16507262
[TBL] [Abstract][Full Text] [Related]
15. Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis.
Korolenko TA; Poteryaeva ON; Djanayeva SJ; Svechnikova IG; Kaledin VI; Timofeyeva OA; Filipenko ML; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):285-92. PubMed ID: 11345040
[TBL] [Abstract][Full Text] [Related]
16. Sialic acid changes in Dalton's lymphoma-bearing mice after cyclophosphamide and cisplatin treatment.
Nicol BM; Prasad SB
Braz J Med Biol Res; 2002 May; 35(5):549-53. PubMed ID: 12011939
[TBL] [Abstract][Full Text] [Related]
17. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
18. Baicalein induces cell death in murine T cell lymphoma via inhibition of thioredoxin system.
Patwardhan RS; Pal D; Checker R; Sharma D; Sandur SK
Int J Biochem Cell Biol; 2017 Oct; 91(Pt A):45-52. PubMed ID: 28864268
[TBL] [Abstract][Full Text] [Related]
19. Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model.
Zacarías Fluck MF; Rico MJ; Gervasoni SI; Ilarregui JM; Toscano MA; Rabinovich GA; Scharovsky OG
Cancer Immunol Immunother; 2007 Feb; 56(2):237-48. PubMed ID: 16733672
[TBL] [Abstract][Full Text] [Related]
20. Influence of Ukrain and cyclophosphamide administration on HA-1 murine hepatoma and LS lymphoma on aspartic proteinase cathepsin D.
Djanayeva SJ; Korolenko TA; Svechnikova IG; Falameyeva OV; Korolenko E; Kaledin VI; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):293-9. PubMed ID: 11345041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
